Stemirna

OverviewSuggest Edit

Stemirna is an RNA technology-based drug development company. It works on mRNA drug projects, focusing on the fields of mRNA-based personalized cancer vaccines, mRNA vaccines for infectious diseases, protein defects diseases, and genetic diseases.

TypePrivate
Founded2016
HQShanghai, CN
Websitestemirna.com

Latest Updates

Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Stemirna

Hangwen Li

Hangwen Li

Founder, President and Chief Executive Officer
Ming Deng

Ming Deng

Vice General Manager
Zhigang Li

Zhigang Li

Vice President
Jeffrey Zhang

Jeffrey Zhang

Chief Operating Officer, Chief Business Officer
Mingjie Wang

Mingjie Wang

Associate Director
Show more

Stemirna Office Locations

Stemirna has an office in Shanghai
Shanghai, CN (HQ)
room 603 - 604, building 2, 1295 Chuanqiao Rd, Pudong Xinqu
Show all (1)

Stemirna Financials and Metrics

Summary Metrics

Founding Date

2016

Stemirna total Funding

$206.5 m

Stemirna latest funding size

$188 m

Time since last funding

5 months ago

Stemirna investors

Stemirna's latest funding round in June 2021 was reported to be $188 m. In total, Stemirna has raised $206.5 m
Show all financial metrics

Stemirna Operating Metrics

May, 2020

Partners

4

Patent Applications

2

Patents Issued

2

Platforms

3
Show all operating metrics

Stemirna Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

Stemirna Online and Social Media Presence

Embed Graph

Stemirna News and Updates

Coronavirus clinical trials to start in April

The vaccine against the coronavirus developed by Chinese scientists is expected to undergo clinical trials in April at the earliest, only two weeks after the virus was isolated.

Chinese Biotech Start-Up Stemirna Therapeutics Raises $14M Series A Round

Stemirna Therapeutics, a Chinese biotech start-up focusing on RNA technology-based drug development, has raised nearly RMB100 million (US$14.16 million) in a serious A round of financing.

Stemirna Frequently Asked Questions

  • When was Stemirna founded?

    Stemirna was founded in 2016.

  • Who are Stemirna key executives?

    Stemirna's key executives are Hangwen Li, Ming Deng and Zhigang Li.

  • Who are Stemirna competitors?

    Competitors of Stemirna include RNAimmune, Moderna and Mercurna.

  • Where is Stemirna headquarters?

    Stemirna headquarters is located at room 603 - 604, building 2, 1295 Chuanqiao Rd, Pudong Xinqu, Shanghai.

  • Where are Stemirna offices?

    Stemirna has an office in Shanghai.

  • How many offices does Stemirna have?

    Stemirna has 1 office.